Literature DB >> 4902894

Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance.

S E Greisman, E J Young, F A Carozza.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 4902894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  34 in total

1.  Mechanisms of endotoxin tolerance. The role of the spleen.

Authors:  S E Greisman; E J Young; J B Workman; R M Ollodart; R B Hornick
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

2.  The nature of endotoxin tolerance.

Authors:  S E Greisman; R B Hornick
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

3.  Response of body temperature and serum iron concentration to repeated pyrogen injection in rabbits.

Authors:  K Goelst; H Laburn
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

4.  Endotoxin lethality and tolerance in mice: analysis with the B-lymphocyte-defective CBA/N strain.

Authors:  N M Zaldivar; I Scher
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Authors:  P M Waring; L J Waring; T Billington; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.

Authors:  C E McCall; L M Grosso-Wilmoth; K LaRue; R N Guzman; S L Cousart
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4.

Authors:  Jennifer C Chase; Jean Celli; Catharine M Bosio
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

8.  Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Staphylococcus aureus.

Authors:  E D Murphey; Geping Fang; Edward R Sherwood
Journal:  Crit Care Med       Date:  2008-11       Impact factor: 7.598

9.  Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Pseudomonas aeruginosa.

Authors:  E D Murphey; E R Sherwood
Journal:  Microbes Infect       Date:  2008-07-17       Impact factor: 2.700

10.  Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis.

Authors:  E T Rietschel; C Galanos
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.